<p>(a) The dose-response curves for the wild type in blue (<i>r</i>(<i>c</i>) = 0.6(1−tanh(15(<i>c</i>−0.3)))) and the resistant strain in red (<i>r</i><sub><i>m</i></sub>(<i>c</i>) = 0.59(1−tanh(15(<i>c</i>−0.6)))) as well as the therapeutic window in green. Red dots indicate the probability of resistance emergence. Probability of resistance emergence is defined as the fraction of 5000 simulations for which resistance reached a density of at least 100 (and thus caused disease).(b) and (c) wild type density (blue), resistant density (red), and immune molecule density (black) during infection for 1000 representative realizations of a stochastic implementation of the model. (b) treatment at the smallest effective dose <i>c</i><sub><i>L</i></s...
<p>The black diamonds show the earliest time at which any one of the resistant strains emerges (reac...
<p>As in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.0030133#pcbi-003...
<p>(A) The probability of developing resistance during continuous therapy as a function of the growt...
<p>(a) The dose-response curves for the wild type in blue (<i>r</i>(<i>c</i>) = 0.6(1−tanh(15(<i>c</...
<p>Here we consider <i>β</i> = 10<sup>−10</sup>. (A) The dosing regimes with no loading dose for 100...
<p>Here we consider <i>β</i> = 10<sup>−10</sup>. (A)–(C): (A) The area under the curve (AUC) of the ...
<p><b>(A)</b> A schematic illustrating how a non-preexisting mutant, A’B’, fully resistant to a comb...
<p>The black diamonds show the probability that any one of the resistant strains emerges (reaches a ...
At the beginning of treatment the population consists of the sensitive strain at its carrying capaci...
<p><b>(A)</b> Theoretical prediction of the treatment duration needed to eliminate each partially re...
<p>(A) We show the probability of resistance, <i>P</i>, over the range of treatment schedules specif...
<p>(<b>A</b>) Shown is the probability that no resistant cells are present at time <i>t</i>, conditi...
<p>(A) Expected number of resistant cancer cells as a function of time during continuous therapy. Bl...
<p>(A), (B) and (C) are examples for sine wave functional forms of birth, death and mutation rates. ...
<p>Boxplots show distribution of times to emergence (resistance at a level of 5% of total infecteds)...
<p>The black diamonds show the earliest time at which any one of the resistant strains emerges (reac...
<p>As in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.0030133#pcbi-003...
<p>(A) The probability of developing resistance during continuous therapy as a function of the growt...
<p>(a) The dose-response curves for the wild type in blue (<i>r</i>(<i>c</i>) = 0.6(1−tanh(15(<i>c</...
<p>Here we consider <i>β</i> = 10<sup>−10</sup>. (A) The dosing regimes with no loading dose for 100...
<p>Here we consider <i>β</i> = 10<sup>−10</sup>. (A)–(C): (A) The area under the curve (AUC) of the ...
<p><b>(A)</b> A schematic illustrating how a non-preexisting mutant, A’B’, fully resistant to a comb...
<p>The black diamonds show the probability that any one of the resistant strains emerges (reaches a ...
At the beginning of treatment the population consists of the sensitive strain at its carrying capaci...
<p><b>(A)</b> Theoretical prediction of the treatment duration needed to eliminate each partially re...
<p>(A) We show the probability of resistance, <i>P</i>, over the range of treatment schedules specif...
<p>(<b>A</b>) Shown is the probability that no resistant cells are present at time <i>t</i>, conditi...
<p>(A) Expected number of resistant cancer cells as a function of time during continuous therapy. Bl...
<p>(A), (B) and (C) are examples for sine wave functional forms of birth, death and mutation rates. ...
<p>Boxplots show distribution of times to emergence (resistance at a level of 5% of total infecteds)...
<p>The black diamonds show the earliest time at which any one of the resistant strains emerges (reac...
<p>As in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.0030133#pcbi-003...
<p>(A) The probability of developing resistance during continuous therapy as a function of the growt...